In order to determine whether UBE4B expression was also associated with RAS/MAPK pathway signaling activity in neuroblastoma tumor cells, we determined levels of UBE4B and total and phosphorylated MEK and ERK expression in established neuroblastoma cell lines and patient tumor samples. This evidence concerns the gene MAP2K7 and neuroblastoma.